1-5 of 5
Maher K. Gandhi
Close
Sort by
Journal Articles

Intratumoral T cells have a differential impact on FDG-PET parameters in follicular lymphoma

Karthik Nath, Soi-Cheng Law, Muhammed B. Sabdia, Jay Gunawardana, Lilia M. de Long, David Sester, Mohamed Shanavas, Hennes Tsang, Joshua W. D. Tobin, Sarah-Jane Halliday, Annette Hernandez, Donna Cross, Robert J. Bird, Sanjiv Jain, Colm Keane, Dipti Talaulikar, Judith Trotman, Phillip Law, Maher K. Gandhi
Journal: Blood Advances
Blood Adv (2021) 5 (12): 2644–2649.
https://doi.org/10.1182/bloodadvances.2020004051
Published: 2021
Includes: Supplemental data
Journal Articles

LAG3: a novel immune checkpoint expressed by multiple lymphocyte subsets in diffuse large B-cell lymphoma

Colm Keane, Soi C. Law, Clare Gould, Simone Birch, Muhammed B. Sabdia, Lilia Merida de Long, Gayathri Thillaiyampalam, Emad Abro, Joshua W. Tobin, Xiaohong Tan, Zijun Y. Xu-Monette, Ken H. Young, Grace Gifford, Sara Gabreilli, William S. Stevenson, Anthony Gill, Dipti Talaulikar, Sanjiv Jain, Annette Hernandez, Sarah-Jane Halliday, Robert Bird, Donna Cross, Mark Hertzberg, Maher K. Gandhi
Journal: Blood Advances
Blood Adv (2020) 4 (7): 1367–1377.
https://doi.org/10.1182/bloodadvances.2019001390
Published: 2020
Includes: Supplemental data
Journal Articles

Outcomes of stage I/II follicular lymphoma in the PET era: an international study from the Australian Lymphoma Alliance

Joshua W. D. Tobin, Gabrielle Rule, Katherine Colvin, Lourdes Calvente, David Hodgson, Stephen Bell, Chengetai Dunduru, James Gallo, Erica S. Tsang, Xuan Tan, Jonathan Wong, Jessica Pearce, Robert Campbell, Shao Tneh, Sophie Shorten, Melissa Ng, Tara Cochrane, Constantine S. Tam, Emad Abro, Eliza Hawkes, Georgina Hodges, Roopesh Kansara, Dipti Talaulikar, Michael Gilbertson, Anna M. Johnston, Kerry J. Savage, Diego Villa, Kirk Morris, Sumi Ratnasingam, Wojt Janowski, Robert Kridel, Chan Y. Cheah, Michael MacManus, Nicholas Matigian, Peter Mollee, Maher K. Gandhi, Greg Hapgood
Journal: Blood Advances
Blood Adv (2019) 3 (19): 2804–2811.
https://doi.org/10.1182/bloodadvances.2019000458
Published: 2019
Includes: Supplemental data
Journal Articles

COO and MYC/BCL2 status do not predict outcome among patients with stage I/II DLBCL: a retrospective multicenter study

Clinical Trials & Observations
Allison Barraclough, Musa Alzahrani, Marianne Schmidt Ettrup, Mark Bishton, Chris van Vliet, Pedro Farinha, Clare Gould, Simone Birch, Laurie H. Sehn, Vishakha Sovani, Mitchell Steven Ward, Bradley Augustson, Jorne Biccler, Joseph M. Connors, David W. Scott, Maher K. Gandhi, Kerry J. Savage, Tarec El-Galaly, Diego Villa, Chan Yoon Cheah
Journal: Blood Advances
Blood Adv (2019) 3 (13): 2013–2021.
https://doi.org/10.1182/bloodadvances.2019000251
Published: 2019
Journal Articles

Human peripheral blood DNAM-1 neg NK cells are a terminally differentiated subset with limited effector functions

Kimberley A. Stannard, Sébastien Lemoine, Nigel J. Waterhouse, Frank Vari, Lucienne Chatenoud, Maher K. Gandhi, Ludovic Martinet, Mark J. Smyth, Camille Guillerey
Journal: Blood Advances
Blood Adv (2019) 3 (11): 1681–1694.
https://doi.org/10.1182/bloodadvances.2018030676
Published: 2019
Includes: Multimedia, Supplemental data